Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ACI's Over the Counter Drugs Boasts a “Who’s Who” of FDA OTC Regulatory & Legal ExpertsPreeminent food & drug lawyers, industry counsel, & regulatory experts representing the OTC pharmaceutical industry together with FDA & USP officials will discuss & share insights on the latest developments affecting non-prescription pharmaceuticals.
Also, in light of recent events concerning enforcement actions and recalls in the OTC industry, the conference will feature sessions on effective recall and remediation strategies, cGMPs, AER review protocols, and FDA, DOJ and FTC enforcement activities. “The FDA’s proposed new paradigm for a third class of drug coupled with recent enforcement activity will change the OTC arena,” said Lisa J. Piccolo, Senior Industry Manager for Life Sciences and Health care at ACI. "We have designed this conference as a comprehensive forum where the latest legal and regulatory developments affecting non-prescription pharmaceutical products can be discussed. We are also delighted to give our delegates the opportunity to hear directly from the FDA and USP on the proposed new paradigm, potential changes to the OTC Review process, and enforcement.” More information about this event, including a full agenda, faculty list, and brochure can be accessed at http://www.AmericanConference.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|